Alon Ben Noon
CEO, NeuroSense Therapeutics
Alon Ben-Noon is co-founder and CEO of NeuroSense Therapeutics, a drug development company focusing on the treatment of ALS and other neurodegenerative diseases.
Show Notes
01:13 Tell us about your career journey and meeting Shay Rishoni
06:25 Tell us about ALS and why it has become a relatively well-known orphan indication
09:30 Tell us about PrimceC
12:40 Could you talk about your financing journey
16:13 Did the crowdfunding process affect your public offering in some sort of way?
18:54 Is it true that zebrafish have over 70% genetic similarity to humans? How is that even possible?
21:00 Could you expand on the leadership team at NeuroSense?
23:10 How has your personal life changed since the company was floated to NASDAQ?
25:00 You have a very unique organizational culture in NeuroSense Therapeutics and you're growing. How do you intend to keep some of that culture while you grow?
27:30 What’s next forNeuroSense? What are the next milestones and pipeline products?
30:15 How long do you expect you are away from the market with the PrimeC?
31:05 Have you put any thoughts to having a companion diagnostic?
32:25 What are your thoughts about the Israeli ecosystem?
34:25 If you could go back to your 16-year-old self and tell yourself something, what do you think it would be?
35:40 Are there any people in your journey that were meaningful to you personally and to NeuroSense Therapeutics
Interview Transcription (mild edits)
Coming soon
Links
(More) Amazing people to learn from
Yotam Drechslet is CEO and Yaron Segal is is CINO (Chief Innovation Officer) of BrainQ Technologies.
Danny Farin is CEO of Perflow Medical, which develops and commercializes devices for stroke. His previous venture, EON Surgical, was sold to Teleflex.
Omri Shor is the co-founder and CEO of Medisafe where for the last decade, he and his team are trying to free patients from the stress of managing complicated medications.
Lena Levin is the co-founder and Via Surgical, the first and only company to create suture-like fixation solutions to address imminent market needs. Her previous venture PolyTouch Medical was acquired back in 2011.
Uri Goren is the head of digital engagement and capabilities at Teva Pharmaceuticals. He is one of the first advocates for patient centric health care.
Nahum Ferera is CEO of EyeYon Medical, a company he co-founded in 2011, that is developing therapies for a range of corneal diseases.